Acknowledgements
The NSF awards (CHE-0821487, CHE-0722547, and
CHE-1048719) are acknowledged. A.S is grateful for the Pro-
vost’s Graduate Student Research Award.
References
1 (a) L. Xiao, X. Lu and D. M. Ruden, Mini-Rev. Med. Chem., 2006, 6,
1137–1143; (b) E. McDonald, K. Jones, P. A. Brough, M. J. Drysdale
and P. Workman, Curr. Top. Med. Chem., 2006, 6, 1193–1203.
2 C. M. Park and D. J. Jeon, Org. Biomol. Chem., 2012, 10, 2613–2620.
3 L. Yan, P. Huo, J. S. Debenham, C. B. Madsen-Duggan, J. Lao,
R. Z. Chen, J. C. Xiao, C.-P. Shen, D. S. Stribling, L. P. Shearman,
A. M. Strack, N. Tsou, R. G. Ball, J. Wang, X. T. J. Bateman,
V. B. G. Reddy, T. M. Fong and J. J. Hale, J. Med. Chem., 2010, 53,
4028–4037.
4 (a) S. Prasanna, E. Manivannan and S. C. Chaturvedi, J. Enzyme Inhib.
Med. Chem., 2005, 20, 455–461; (b) S. M. Sakya, X. Hou, M. L. Minich,
B. Rast, A. Shavnya, K. M. L. DeMello, H. Cheng, J. Li, B. H. Jaynes,
D. W. Mann, C. F. Petras, S. B. Seibel and M. L. Haven, Bioorg. Med.
Chem. Lett., 2007, 17, 1067–1072; (c) M. A. Chowdhury,
K. R. A. Abdellatif, Y. Dong, D. Das, M. R. Suresh and E. E. Knaus,
J. Med. Chem., 2009, 52, 1525–1529.
Fig. 2 An ORTEP view of the 3e illustrating atom labeling scheme
and thermal ellipsoids (50% probability level). Selected interatomic dis-
tances (Å): N1–N2 1.364(2), N2–C3 1.335(2), C3–C4 1.411(2), C4–C5
1.374(3), C5–N1 1.362(2). Key angles (°): N1–N2–C3 104.64(13), N2–
C3–C4 110.77(15), C3–C4–C5 106.22(15), C4–C5–N1 105.64(15),
C5–N1–N2 112.73(14).
1
and 5-cyclopropylmethylene-substituted pyrazoles. H and 13C
5 S. Brand, L. A. T. Cleghorn, S. P. McElroy, D. A. Robinson, V. C. Smith,
I. Hallyburton, J. R. Harrison, N. R. Norcross, D. Spinks, T. Bayliss,
S. Norval, L. Stojanovski, L. S. Torrie, J. A. Frearson, R. Brenk,
A. H. Fairlamb, M. A. J. Ferguson, K. D. Read, P. G. Wyatt and
I. H. Gilbert, J. Med. Chem., 2012, 55, 140–152.
NMR spectra are provided in the electronic ESI.†
Presumably the reaction mechanism includes a sequence
of consecutive formation of a hydrazone and intramolecular 5-
exo-dig cyclization reaction that constitute a formal hydrohydra-
zidation of an alkyne (Scheme 2). Isomerization of benzylidene
derivative 6, driven by aromatization, leads to the final product
3. Required hydrogen migration may contribute to a necessity of
elevated temperature for this reaction to proceed. However,
initial formation of an allene, such as 7, that would subsequently
cycloisomerize cannot be excluded.24
6 (a) H. Wong, M. Belvin, S. Herter, K. P. Hoeflich, L. J. Murray, L. Wong
and E. F. Choo, J. Pharmacol. Exp. Ther., 2009, 329, 360–367;
(b) K. P. Hoeflich, S. Herter, J. Tien, L. Wong, L. Berry, J. Chan,
C. O’Brien, Z. Modrusan, S. Seshagiri, M. Lackner, H. Stern, E. Choo,
L. Murray, L. S. Friedman and M. Belvin, Cancer Res., 2009, 69, 3042–
3051; (c) B. A. Thaher, M. Arnsmann, F. Totzke, J. E. Ehlert,
M. H. G. Kubbutat, C. Schächtele, M. O. Zimmermann, P. Koch,
F. M. Boeckler and S. A. Laufer, J. Med. Chem., 2012, 55, 961–965.
7 R. Neelarapu, D. L. Holzle, S. Velaparthi, H. Bai, M. Brunsteiner,
S. Y. Blond and P. A. Petukhov, J. Med. Chem., 2011, 54, 4350–4364.
8 Recent representative reviews: (a) J.-Y. Yoon, S-g. Lee and H. Shin,
Curr. Org. Chem., 2011, 15, 657–674; (b) J. Elguero, A. M. S. Silva,
A. C. Tomé, Five-Membered Heterocycles: 1,2-Azoles. Part 1. Pyrazoles,
in Modern Heterocyclic Chemistry, ed. J. Alvarez-Builla, J. J. Vaquero
and J. Barluenga, Wiley-VCH, Weinheim, 2011, vol. 2, ch. 8,
pp. 635–725; (c) A. Schmidt and A. Dreger, Curr. Org. Chem., 2011, 15,
1423–1463; (d) L. Yet, Pyrazoles, in Comprehensive Heterocyclic Chem-
istry III, ed. A. R. Katritzky, C. H. Ramsden, E. F. V. Scriven and
R. J. K. Taylor, Elsevier, New York, 2008, vol. 4, ch. 1, pp. 1–141;
(e) L. Yet, Prog. Heterocycl. Chem., 2011, 23, 231–266; (f) L. Yet, Prog.
Heterocycl. Chem., 2012, 24, in press.
9 (a) M. Zora and A. Kivrak, J. Org. Chem., 2011, 76, 9379–9390. See
also: (b) B. C. Bishop, K. M. J. Brands, A. D. Gibb and D. J. Kennedy,
Synthesis, 2004, 43–52; (c) H. Garia, S. Iborra, M. A. Miranda,
I. M. Morera and J. Primo, Heterocycles, 1991, 32, 1745–1755.
10 D. Obermayer, T. N. Glasnov and O. C. Kappe, J. Org. Chem., 2011, 76,
6657–6669.
Scheme 2 Mechanistic outline for the synthesis of pyrazoles 3 via
cyclocondensation of 5 and hydrazines.
11 Selected recent representative advances: (a) R. E. Beveridge and
R. A. Batey, Org. Lett., 2012, 14, 540–543; (b) J. Z. Chandanshive,
P. B. González, W. Tiznado, B. F. Bonini, J. Caballero, C. Femoni and
M. Comes Franchini, Tetrahedron, 2012, 68, 3319–3328; (c) D. Verma,
S. Shaikh Mobin and I. N. N. Namboothiri, J. Org. Chem., 2011, 76,
4764–4770; (d) M. Zora, A. Kivrak and C. Yazici, J. Org. Chem., 2011,
76, 6726–6742; (e) D. J. Babinski, H. R. Aguilar, R. Still and
D. E. Frantz, J. Org. Chem., 2011, 76, 5915–5923; (f) R. Surmont and
G. N. De Kimpe, Org. Lett., 2010, 12, 4648–4651.
12 (a) D. M. Shen, E. J. Brady, M. R. Candelore, Q. Dallas-Yang,
V. D.-H. Ding, W. P. Feeney, G. Jiang, M. E. McCann, S. Mock,
S. A. Qureshi, R. Saperstein, X. Shen, X. Tong, L. M. Tota, M. J. Wright,
X. Yang, S. Zheng, K. T. Chapman, B. B. Zhang, J. R. Tata and
E. R. Parmee, Bioorg. Med. Chem. Lett., 2011, 21, 76–81; (b) Potent AT1
selective angiotensin II receptor antagonists: .C. Almansa, L. A. Gómez,
F. L. Cavalcanti, A. F. de Arriba, J. García-Rafanell and J. Forn, J. Med.
Chem., 1997, 40, 547–558.
In summary, we have demonstrated that the combination of a
condensation reaction with subsequent 5-exo-dig cyclization pro-
vides an efficient system for the synthesis of pyrazoles. The
method provides effective access to diversely substituted 1,3,5-
trisubstituted pyrazoles. The solvent-free conditions provide an
appealing protocol that includes formation of two C–N bonds
and does not even require isolation of hydrazone. This method
facilitates the regioselective positioning of hydrazine within two
available locations. Moreover, it also allows for the introduction
of benzyl type substituents (such as p-methylbenzyl) at the C-5
of pyrazole that is not easily carried out by currently available
methods.25
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 4505–4508 | 4507